AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Piano, E Dall'aglio, GA Chittofrati, R Crivello, S Puppo, F
Citation: E. Piano et al., A non-destructive interferometric technique for analysis of crystal growthand fluid dynamics, ANN CHIM-SC, 26(1), 2001, pp. 23-28

Authors: Ghio, M Contini, P Mazzei, C Merlo, A Filaci, G Setti, M Indiveri, F Puppo, F
Citation: M. Ghio et al., In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion?, TRANSFUSION, 41(8), 2001, pp. 988-996

Authors: Puppo, F Ghio, M Contini, P Mazzei, C Indiveri, F
Citation: F. Puppo et al., Fas, Fas ligand, and transfusion immunomodulation, TRANSFUSION, 41(3), 2001, pp. 416-418

Authors: Filaci, G Bacilieri, S Fravega, M Monetti, M Contini, P Ghio, M Setti, M Puppo, F Indiveri, F
Citation: G. Filaci et al., Impairment of CD8(+) T suppressor cell function in patients with active systemic lupus erythematosus, J IMMUNOL, 166(10), 2001, pp. 6452-6457

Authors: Ghio, M Contini, P Mazzei, C Brenci, S Filaci, G Indiveri, F Puppo, F
Citation: M. Ghio et al., Soluble HLA class I and Fas ligand molecules in blood components and theirrole in the immunomodulatory effects of blood transfusions, LEUK LYMPH, 39(1-2), 2000, pp. 29-36

Authors: Puppo, F Contini, P Ghio, M Brenci, S Scudeletti, M Filaci, G Ferrone, S Indiveri, F
Citation: F. Puppo et al., Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes, INT IMMUNOL, 12(2), 2000, pp. 195-203

Authors: Patrone, G Puppo, F Cusano, R Scaranari, M Ceccherini, I Puliti, A Ravazzolo, R
Citation: G. Patrone et al., Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT-PCR, BIOTECHNIQU, 29(5), 2000, pp. 1012

Authors: Puppo, F Torre, F Contini, P Ghio, M Brenci, S Brizzolara, R Sinelli, N Campo, N Indiveri, F Picciotto, A
Citation: F. Puppo et al., Soluble beta(2)-mu-associated and beta(2)-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients.Markers of immune activation, and response to antiviral retreatment, J CLIN IMM, 20(6), 2000, pp. 486-490

Authors: Piano, E Dall'Aglio, GA Crivello, S Chittofrati, R Puppo, F
Citation: E. Piano et al., New optical techniques for crystal growth from fluids, MATER CH PH, 66(2-3), 2000, pp. 266-269

Authors: Contini, P Ghio, M Merlo, A Brenci, S Filaci, G Indiveri, F Puppo, F
Citation: P. Contini et al., Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8(+)cytotoxic T lymphocytes by Fas/Fas-ligand interaction, HUMAN IMMUN, 61(12), 2000, pp. 1347-1351

Authors: Campo, N Brizzolara, R Sinelli, N Puppo, F Campelli, A Indiveri, F Picciotto, A
Citation: N. Campo et al., Hepatitis G virus infection in intravenous drug users with or without human immunodeficiency virus infection, HEP-GASTRO, 47(35), 2000, pp. 1385-1388

Authors: Puppo, F Brenci, S Contini, P Bignardi, D Hamby, CV Filaci, G Ghio, M Scudeletti, M Picciotto, A Indiveri, F Ferrone, S
Citation: F. Puppo et al., Increased beta 2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens, TISSUE ANTI, 55(4), 2000, pp. 333-341

Authors: Filaci, G Cutolo, M Scudeletti, M Castagneto, C Derchi, L Gianrossi, R Ropolo, F Zentilin, P Sulli, A Murdaca, G Ghio, M Indiveri, F Puppo, F
Citation: G. Filaci et al., Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy, RHEUMATOLOG, 38(10), 1999, pp. 992-996

Authors: Puppo, F Costa, M Contini, P Brenci, S Cevasco, E Ghio, M Norelli, R Bensussan, A Capitanio, GL Indiveri, F
Citation: F. Puppo et al., Determination of soluble HLA-G and HLA-A, -B, and -C molecules in pregnancy, TRANSPLAN P, 31(4), 1999, pp. 1841-1843

Authors: Ghio, M Contini, P Mazzei, C Brenci, S Barberis, G Filaci, G Indiveri, F Puppo, F
Citation: M. Ghio et al., Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions, BLOOD, 93(5), 1999, pp. 1770-1777

Authors: Puppo, F Bignardi, D Contini, P Brenci, S Lanza, L Ghio, M Scudeletti, M Indiveri, F Ferrone, S
Citation: F. Puppo et al., beta(2)-mu-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta(2)-mu-associated HLA class I heavy chainlevels and HLA phenotype, TISSUE ANTI, 53(3), 1999, pp. 253-262

Authors: Filaci, G Contini, P Grasso, I Bignardi, D Ghio, M Lanza, L Scudeletti, M Puppo, F Bolognesi, M Accolla, RS Indiveri, F
Citation: G. Filaci et al., Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation, EUR J IMMUN, 28(12), 1998, pp. 3968-3979
Risultati: 1-17 |